Published in Int J Mol Sci on February 06, 2016
Drug, Herb, and Dietary Supplement Hepatotoxicity. Int J Mol Sci (2016) 0.75
Drug-induced liver injury: Towards early prediction and risk stratification. World J Hepatol (2017) 0.75
Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Int J Mol Sci (2017) 0.75
Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Sci Rep (2017) 0.75
Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury. Int J Mol Sci (2017) 0.75
Liver injury after aluminum potassium sulfate and tannic acid treatment of hemorrhoids. World J Gastroenterol (2017) 0.75
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology (2008) 5.45
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology (2005) 3.52
Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology (2013) 2.72
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology (2015) 2.43
Outcome and prognostic markers in severe drug-induced liver disease. Hepatology (2005) 2.36
Drug-induced liver injury following positive drug rechallenge. Regul Toxicol Pharmacol (2009) 2.17
Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol (2004) 1.95
The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology (1993) 1.58
A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy (1997) 1.55
Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol (2010) 1.50
RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci (2015) 1.45
Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. Drug Saf (2010) 1.10
Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol (2010) 1.07
Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports. Hepatology (2015) 1.05
Severe hepatitis in three AIDS patients treated with indinavir. Lancet (1997) 1.04
Rechallenge in drug-induced liver injury: the attractive hazard. Expert Opin Drug Saf (2009) 0.91
Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges. Drug Saf (2014) 0.89
Indinavir-associated hepatitis in patients with advanced HIV infection. Int J STD AIDS (1998) 0.83
Discrepancies in liver disease labeling in the package inserts of commonly prescribed medications. Gastroenterology (2014) 0.81
Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimen. AIDS (2007) 0.79